PureTech Health Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	191.08	149.87	465.71	403.88	132.36	117.05
Short-Term Investments	137.69	202.8	17.66	2.51	32.56	136.03
Cash & Cash Equivalents	328.77	352.67	483.37	406.39	164.92	253.08
Cash Growth	-6.78%	-27.04%	18.94%	146.41%	-34.83%	-
Receivables	2.38	11.87	3.17	2.56	1.98	1.33
Other Current Assets	16.05	21.66	15.27	5.4	1.95	5.38
Total Current Assets	347.2	386.19	501.81	414.35	168.85	259.79
Property, Plant & Equipment	19.36	37.24	43.94	42.88	43.84	8.32
Long-Term Investments	325.63	278.38	398.46	531.86	727.63	169.76
Goodwill and Intangibles	0.91	0.83	0.99	0.9	0.63	3.08
Other Long-Term Assets	0.88	0.01	0.81	0.01	0.24	0.82
Total Long-Term Assets	346.77	316.46	444.2	575.65	772.33	181.98
Total Assets	693.97	702.65	946.01	989.99	941.18	441.76
Accounts Payable	44.11	54.84	35.82	21.83	19.84	15.88
Deferred Revenue	0	2.19	0.07	1.47	6.69	6.64
Current Debt	7.09	12.47	9.45	29.72	4.38	12.01
Other Current Liabilities	0.17	27.39	180.81	127.91	108.28	231.24
Total Current Liabilities	51.37	96.89	226.14	180.92	139.2	265.76
Long-Term Debt	18.25	34.4	43.3	46.91	34.91	0
Other Long-Term Liabilities	166.12	23.77	92.42	108.63	116.67	9.03
Total Long-Term Liabilities	184.37	58.17	135.72	155.53	151.58	9.03
Total Liabilities	235.74	155.06	361.86	336.46	290.78	274.79
Total Debt	25.34	46.87	52.75	76.62	39.3	12.01
Debt Growth	-45.93%	-11.14%	-31.16%	94.98%	227.21%	-
Retained Earnings	83.82	149.52	199.87	260.43	254.44	-167.69
Comprehensive Income	0.18	0.09	0.47	0.47	0	0.01
Shareholders' Equity	464.07	542.22	593.52	669.75	668.04	275.51
Net Cash / Debt	303.43	305.8	430.62	329.76	125.62	241.07
Net Cash / Debt Growth	-0.77%	-28.99%	30.58%	162.50%	-47.89%	-
Working Capital	295.83	289.31	275.67	233.42	29.64	-5.98
Book Value Per Share	16.66	18.84	20.76	23.44	23.38	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).